Literature DB >> 3417805

The diagnosis of childhood hyperactivity. A U.S.-U.K. cross-national study of DSM-III and ICD-9.

M Prendergast1, E Taylor, J L Rapoport, J Bartko, M Donnelly, A Zametkin, M B Ahearn, G Dunn, H M Wieselberg.   

Abstract

The unequal prevalence of hyperactivity in Britain and the U.S. was investigated with a cross-national diagnostic study. Case histories of 6-11-yr-old boys were evaluated by British and American research teams as well as British and American clinician panels using both ICD-9 and DSM-III. Interrater agreement was acceptably high only for the specially trained research teams. ICD-9 generated fewer diagnoses of Hyperkinetic Syndrome than did DSM-III of Attention Deficit Disorder with Hyperactivity. The difference was greatest for U.K. clinicians. Diagnostic scheme and clinician training both contribute to the difference in reported rates.

Entities:  

Mesh:

Year:  1988        PMID: 3417805     DOI: 10.1111/j.1469-7610.1988.tb00717.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  28 in total

Review 1.  Types of psychiatric treatment. Drug treatment.

Authors:  M Prendergast
Journal:  Arch Dis Child       Date:  1992-12       Impact factor: 3.791

2.  ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument.

Authors:  S Zhang; D E Faries; M Vowles; D Michelson
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

3.  Diagnosis in adolescent inpatients: diagnostic confidence and comparison of diagnoses using ICD-9 and DSM-III.

Authors:  R J McCabe; D J Rothery; R M Wrate; J Aspin; J G Bryce
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-09       Impact factor: 4.785

Review 4.  Priority mental health disorders of children and adolescents in primary-care pediatric settings in India 2: diagnosis, pharmacological treatment and referral.

Authors:  P S Russell; M K C Nair; P Mammen; S R Shankar
Journal:  Indian J Pediatr       Date:  2011-05-27       Impact factor: 1.967

5.  Attention-deficit hyperactivity disorder.

Authors:  D C Meek
Journal:  Can Fam Physician       Date:  1990-09       Impact factor: 3.275

6.  Do we need an Ofhealth?

Authors:  C Propper; C ] Popper C [corrected to Propper
Journal:  BMJ       Date:  1995-06-24

Review 7.  Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder.

Authors:  M Cyr; C S Brown
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

8.  Prepubertal mania: diagnostic differences between US and UK clinicians.

Authors:  Bernadka Dubicka; Gabrielle A Carlson; Andy Vail; Richard Harrington
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04       Impact factor: 4.785

9.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

Review 10.  DSM-V and the future diagnosis of attention-deficit/hyperactivity disorder.

Authors:  James M Swanson; Timothy Wigal; Kimberley Lakes
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.